One of the first protein polymorphisms identified in humans involves the abundant blood protein haptoglobin. Two exons of the HP gene (encoding haptoglobin) exhibit copy number variation that affects HP protein structure and multimerization. The evolutionary origins and medical relevance of this polymorphism have been uncertain. Here we show that this variation has likely arisen from many recurring deletions, more specifically, reversions of an ancient hominin-specific duplication of these exons. Although this polymorphism has been largely invisible to genome-wide genetic studies thus far, we describe a way to analyze it by imputation from SNP haplotypes and find among 22,288 individuals that these HP exonic deletions associate with reduced LDL and total cholesterol levels. We further show that these deletions, and a SNP that affects HP expression, appear to drive the strong association of cholesterol levels with SNPs near HP. Recurring exonic deletions in HP likely enhance human health by lowering cholesterol levels in the blood.
A r t i c l e s
The HP protein binds free hemoglobin and facilitates its removal from the bloodstream 1, 2 . A common 1.7-kb copy number variant (CNV) inside the HP gene determines the copy number (generally 1 or 2) of a tandem two-exon segment, including sequence that encodes a multimerization domain. This CNV is responsible for a striking protein phenotype: HP circulates as a dimer in individuals who are homozygous for the HP1 allele (encoding a single copy of the multimerization domain), but it forms multimers in individuals with the two-copy HP2 allele [3] [4] [5] (Fig. 1) . HP2 is also a less efficient antioxidant than HP1 (ref. 6) , and HP2 is required to make the tight-junction modulator protein zonulin, which is the preprocessed product of HP2 (ref. 7) . Whether such functional variation contributes to human phenotypes is not well understood.
The alleles of HP are further divided into subtypes by nucleotide polymorphisms that cause HP to run faster or slower on a protein gel 8 , hereafter called the 'F' and 'S' alleles, respectively. Both F and S alleles segregate on the HP1 background, creating the subtypes HP1F and HP1S. The most common form of HP2 contains both alleles (as paralogous sequence variants) and is called HP2FS, but a low-frequency HP2SS form also exists 9 . There are no known functional differences between the F and S alleles.
Despite the functional importance of haptoglobin-which constitutes one of the five most abundant proteins in blood 10 -and the potential functional importance of the common CNV that affects its structure, analyzing the association of this CNV with human phenotypes has proven challenging, and the CNV's relationship to genomewide association study (GWAS) signals near HP has been unclear 11 . The CNV is not in strong linkage disequilibrium (LD) with any individual SNP 11 , and it has not been successfully genotyped with array-based copy number analysis 12 or low-coverage sequencing 13 . Instead, the polymorphism is generally typed with protein PAGE 14 , PCR 15 or quantitative PCR 16 , which has in practice restricted the size of most association studies. Although the HP polymorphism-one of the earliest polymorphisms to be discovered in humans-has been analyzed in hundreds of studies for associations with many human phenotypes, the limited sample sizes of these studies have provided insufficient power to determine whether the common HP CNV, or other nearby genetic variation, contributes to genetically complex phenotypes.
Blood cholesterol levels are one of the most important known biomarkers for future health and mortality 17 . A GWAS for cholesterol levels found a definitive signal (P = 3 × 10 −24 ) at markers near HP 18 , but, as at most GWAS-implicated loci, the causal variant(s) explaining this association are not known. Although the HP protein's most familiar role is to bind hemoglobin, HP also binds cholesterol molecules [19] [20] [21] [22] . We hypothesized that the HP CNV might be responsible for the genetic association of cholesterol levels with this locus. To investigate this relationship, we had to develop ways to understand a surprisingly complex form of structural variation and its relationships to SNPs and haplotypes.
RESULTS

A revised structural history of the haptoglobin gene
The alleles and mutational history of a locus provide a context for understanding whether and how the locus generates phenotypic variation. Standard genomics approaches, such as LD-based and array-based Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels 3 6 0 VOLUME 48 | NUMBER 4 | APRIL 2016 Nature GeNetics A r t i c l e s Figure 1 A common CNV in the HP gene is responsible for distinct molecular phenotypes. The HP2 allele contains two additional exons as compared to the HP1 allele: exons 3 and 4 are analogous to exons 5 and 6, respectively. The boundaries of the CNV are shown by the gray boxes on the gene diagrams. The HP1 allele contains one copy of sequence in exon 3 (orange), which encodes the protein multimerization domain, allowing dimers to be formed. HP2 has two copies of this multimerization domain, which results in the formation of multimers. Exons 4 and 6 (green) contain the F/S mutations responsible for the protein running faster or slower on a gel. The long final exon of HP1 and HP2 encodes the β subunit of the protein (blue), whereas the earlier exons encode the α subunit (green and orange). The α and β subunits are cleaved apart by proteolytic processing after translation but are held together by disulfide bonds 5 . The protein isoform diagrams shown here were modeled after those in an earlier publication 5 . Figure 2 SNP haplotypes surrounding HP persist through the CNV region yet segregate with both structural forms of HP. This plot displays the SNP haplotypes (10 kb on each side of the HP CNV) segregating with HP1 and HP2 based on an analysis of 264 samples (528 haplotypes). The upstream SNPs are proximal to the centromere, whereas the downstream SNPs are distal to the centromere. Each thin horizontal line represents an individual SNP haplotype; similar or identical haplotypes are organized into clusters outlined by colored boxes. Note that the size of small clusters has been increased for visibility purposes, and the number of haplotypes contained in each cluster is indicated at the left of the plot. White represents the minor allele and gray indicates the major allele across all populations in the analysis (CEU, IBS, TSI, YRI). Haplotypes ascertained from West African (HapMap YRI) individuals are indicated with lavender bars to the left of the plot, while haplotypes ascertained in European populations (CEU, IBS, TSI) are indicated with dark purple bars to the left of the plot. Haplotypes were clustered with the k-means method using upstream SNP haplotypes. Similar SNP haplotypes carrying different structures are indicated with colored outlines (dark pink, light blue, green, gold) and are designated haplotypes A-D. This figure was based on analysis of 1000 Genomes Project samples and data (Online Methods).
CNV analyses,
have not yet successfully captured structural variation in HP 11 ; we sought to determine why standard methods have failed and to develop a new approach.
The long-accepted model of HP structural evolution 23 proposed that HP2 arose through non-homologous recombination between HP1F and HP1S to produce HP2FS. The assumption that HP2 was formed by the fusion of human HP1 alleles arose from the observation that non-human great apes lack HP2 (ref. 24) and that the left and right copies of the sequence in HP2FS are similar to sequences in HP1F and HP1S, respectively 23 . However, the low LD between the HP CNV and surrounding SNPs potentially suggests a more complex structural history, as has been noted previously 25 . We first sought to distinguish between the two forces that reduce LD between nearby loci: (i) recombination and (ii) recurrent mutation. If the low LD (of the CNV with flanking SNPs) were caused by frequent homologous recombination near the HP CNV region, then SNPs on the left and right sides of the structural variation would have low LD to one another. Conversely, if HP structure were affected by recurring intrachromosomal structural mutations (or by non-allelic recombination between identical sister chromatids), then low LD between SNPs and the CNV might still be accompanied by high LD between SNPs on either side of the CNV.
We used droplet digital PCR (ddPCR) 26 to genotype the HP CNV in 264 unrelated individuals sampled by the 1000 Genomes Project 13 , phased the structural alleles onto SNP haplotypes using low-coverage sequence data 27 and clustered similar SNP haplotypes (Online Methods). We observed that, although many pairs of SNPs on opposite sides of the CNV were in high LD with each other (r 2 > 0.95) ( Supplementary  Fig. 1 ), copy number of the HP exons was not strongly correlated with any SNP on either side (maximum r 2 = 0.44 in Europeans from the 1000 Genomes Project). Three common SNP haplotypes (denoted A, B and C in Fig. 2 ) persisted through the CNV region yet segregated with both the HP1 and HP2 forms, a pattern that appears consistent with recurring structural mutations at HP (Fig. 2) .
We next sought to determine whether structural mutations at HP involved deletions or duplications by analyzing the nucleotide variation in the CNV region. We classified 27 haplotypes as one of four conventional subtypes-HP1S, HP1F, HP2FS or HP2SS-on the basis of known sequence differences 23 . For HP2 haplotypes, we refer to the left copy of the CNV as HP2-left (which is proximal to the centromere 
A r t i c l e s and 5′ on the transcribed RNA) and to the right copy as HP2-right (distal to the centromere and 3′ on the transcribed RNA) (Fig. 3a) . Some 42 nucleotide polymorphisms differed among the subtypes of HP (for example, between HP2FS and HP1S) but were consistent for any given subtype ( Fig. 3a and Supplementary Fig. 2 Fig. 3 ). This analysis showed that HP1F and HP2FS-left (the left copy of the CNV segment on HP2FS) share a 300-bp segment containing 30 derived variants that is nearly identical to a portion of the human HPR gene. This segment is likely the result of paralogous gene conversion, through which a segment of HPR sequence was transferred into the HP gene ( Fig. 3a and Supplementary Figs. 2 and 3 ). This gene conversion is responsible for the F mutations in HP1F and HP2FS. We believe that this gene conversion event has complicated detection of the CNV in genomic studies, as the copy number-variable sequence can appear to arise partly from HP and partly from HPR, and likely explains why CNV data resources 12, 13 have lacked genotypes for this CNV. Our analysis also identified a highly diverged 250-bp region that has ten fixed differences (between subtypes), including a mixture of derived and ancestral alleles in each segment ( Fig. 3a and Supplementary Figs. 2  and 3) . We refer to this sequence as the 'highly diverged region' and call the allele present in HP1S, HP1F and HP2-right 'form R' and the allele present in HP2-left 'form L' . We confirmed that these sequence differences are consistent at the population level by genotyping the boundaries of each variable region using ddPCR in DNA from 590 individuals sampled by HapMap 28 and the 1000 Genomes Project 27 (Fig. 3b , Online Methods and Supplementary Fig. 4) .
The sequence differences between the HP subtypes shown in Figure 3 indicate that neither modern HP2 subtype (HP2FS nor HP2SS) could be created through the fusion of known HP1F and HP1S subtypes in the way that the earlier model 23 proposed (Fig. 3c) ; for the earlier model to be true, HP2 would need to have arisen from a fusion of HP1S with a hypothetical diverged HP1 allele (containing form L of the highly diverged region) that no longer segregates at an appreciable frequency in human populations. Alternatively, we propose that HP2 could be much older than previously thought, allowing these (non-allelic) sequences the time to diverge strongly from each other as paralogous sequence variants on an HP2 structure. HP2 does have all the sequences required to form HP1 alleles by simple non-allelic homologous recombination (NAHR) between the two tandem copies of the two-exon segment on HP2FS (Fig. 3d) .
Flanking SNP haplotypes also suggest that HP2 did not arise from recombination between HP1F and HP1S. All HP1F alleles segregate with SNP haplotype B, and almost all HP1S alleles segregate with SNP haplotype A (Supplementary Fig. 5 ). If HP2 had been created via non-allelic recombination between these two alleles, SNP haplotype B would be upstream of HP2 and SNP haplotype A would be downstream (Fig. 3c) ; however, characteristic HP2 SNP haplotypes persist across the CNV region and do not appear to involve such recombinant haplotypes ( Fig. 3d; see Supplementary Fig. 6 for our complete model of HP structural evolution).
An alternative model would be that HP2 is in fact the ancestral allele in humans and that HP1 alleles arose (and may continue to arise) by simple exonic deletions (due to NAHR) on an HP2 background. HP2-to-HP1 deletions have been observed at low frequency in the somatic and sperm cells of homozygous-HP2 individuals 29 , demonstrating that the HP gene is prone to this type of structural mutation.
We sought to use information from long SNP haplotypes to further evaluate the alternative hypothesis that HP2-to-HP1 deletions gave rise to the structural variation at HP. If HP2-to-HP1 deletions occur intrachromosomally (or between sister chromatids) and are transmitted to offspring, then rare HP1 subtypes might segregate on SNP haplotypes that are usually associated with common HP2 subtypes. Whereas the short (10-kb) haplotypes immediately around HP cluster into a small number of groups (Fig. 2) , we found that longer SNP haplotypes have much more information and cluster into a larger number of smaller groups (Fig. 4) . A dendrogram analysis of these longer haplotypes showed that several common HP2FS-flanking SNP haplotypes also contain rare (singleton) HP1S alleles (Fig. 4 and Online Methods). Fig. 2 ). This recombination event appears to be recent because it is identical to standard haplotypes for at least 20 kb on either side of the CNV.
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A r t i c l e s allele. However, high-coverage genome sequences from ancient hominins are now available. We found that the Homo neanderthalensis 31 and Homo denisova 32 genomes both have many sequence reads containing the breakpoint sequence that is present on HP2 but not on HP1 and that they also contain all other sequences that define the HP2FS subtype (Supplementary Table 1 ). The presence of HP2FS in Neanderthals, Denisovans, and both modern and ancient 33 African humans ( Fig. 3b and Supplementary Table 1) indicates that HP2 arose before the divergence of these hominins 400 to 600 thousand years ago 34 . (An earlier study, which assumed that HP2 was the derived allele, estimated the age of HP2 at less than 100 thousand years 30 , but this is contradicted by the ancient hominin genome sequences 31, 32 .) SNP haplotypes further support the idea that HP2 is an ancient structural form: unlike HP1, HP2 segregates on all four common human SNP haplotypes identified at this locus (A-D in Fig. 2 ).
HP structural alleles can be imputed from SNP haplotypes
It is important to understand how complex, recurring variation contributes to human phenotypes. The gene conversion history and limited LD between the HP CNV and surrounding SNPs have made it challenging to study this structural variation. We sought to develop a way to integrate HP structural variation into large-scale genetic studies whose large sample sizes enable robust analysis of relationships with phenotypes. We hypothesized that, although HP structural mutations have occurred many times among human ancestors, the subset of these mutations that are old and common today might segregate on characteristic SNP haplotypes in many different individuals. Indeed, the above analysis of highly specific SNP haplotypes showed that such haplotypes usually segregate with a characteristic HP structural allele (Fig. 4) .
Four of these rare HP1S structures segregate with SNP haplotypes that are identical to common HP2FS SNP haplotypes for at least 20 kb on either side of the CNV. The HP2FS and HP1S alleles from the same SNP haplotype branch also share derived mutations within the CNV region, consistent with shared ancestry (Supplementary Fig. 7 ).
These observations indicate that these four HP1S alleles likely result from recent exonic deletions that occurred on an earlier HP2 allele. We also identified a SNP haplotype that carried the HP2FS allele in 15 of 16 sampled Africans but had the HP1S allele in 16 of 16 sampled Europeans, consistent with a deletion event in an African ancestor whose descendants migrated to Europe (Fig. 4) . We conclude that HP structural variation reflects a combination of ancient and recent deletions that continue to create HP1 alleles from HP2 alleles. For common HP1 alleles to be derived deletions, HP2 would have to be ancient. The HP2 allele has not been observed in non-human primates, prompting the earlier model 23 that it was a derived, recent 30 This table shows the correlation (r 2 ) between HP structural alleles (as identified by direct molecular analysis) and predictions from imputation from SNP haplotypes, using SNPs on the Illumina Omni2.5 array. The correlation between each structural feature and the most strongly correlated individual SNP is also displayed. The CEU, IBS and TSI populations were merged into a single European population for this analysis. -log 10 (P) Figure 5 The HP2 allele associates with increased total cholesterol levels and increased LDL cholesterol levels. The imputed structural variants and all regional SNPs imputed from 1000 Genomes Project data are shown for this analysis of 22,288 individuals. (a,b) The HP2 variant is the strongest regional association for both total cholesterol levels (P = 2.79 × 10 −11 ) (a) and LDL cholesterol levels (P = 4.3 × 10 −9 ) (b). (c,d) Conditioning on the HP2 variant causes most of the association of the GWAS index SNP with total cholesterol levels (P = 0.006) (c) and LDL cholesterol levels (P = 0.004) (d) to disappear. (e,f) Conditioning on the GWAS index SNP only has a moderate effect on the association of HP2 with total cholesterol levels (P = 5.95 × 10 -7 ) (e) and LDL cholesterol levels (P = 2.02 × 10 -5 ) (f).
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A r t i c l e s
To test this hypothesis, we phased HP structural alleles with SNP haplotypes to create reference chromosomes for imputation [35] [36] [37] (Supplementary Data Set). To measure the efficacy of imputation (using Beagle 35 ), we implemented a series of leave-one-out trials, in each of which we removed an individual's HP gene structure from the reference panel and attempted to infer what structure was present on the basis of the surrounding SNP haplotype and the rest of the reference panel (Online Methods and Supplementary Note). Although no individual SNP 'tagged' HP CNV status (HP2 versus HP1) with high accuracy (maximum r 2 = 0.44), we were able to impute HP CNV status from multi-SNP haplotypes in both African and European population samples with high accuracy (r 2 = 0.94 in a European (CEU, IBS, TSI) population sample and r 2 = 0.92 in a Yoruba (YRI) sample), using only SNPs present on common SNP genotyping arrays ( Table 1, Supplementary Fig. 8 and Supplementary Tables 2-5 ). We believe this result reflects the fact that, despite recurring mutation at HP, most HP1 alleles trace back to a few ancient mutations in common ancestors (more recent deletion events likely reduce the efficacy of imputation but are more rare) ( Table 1) . Our imputation approach allows HP structural variation to be incorporated into large genetic studies using existing SNP data.
Haptoglobin and blood cholesterol levels
Both total cholesterol and low-density lipoprotein (LDL) cholesterol levels associate strongly (P = 3 × 10 −24 and 2 × 10 −22 , respectively, in a cohort of >100,000 individuals 18 ) with the SNP rs2000999, which is within 15 kb of HP. Given that the HP protein binds to multiple types of cholesterol molecules [19] [20] [21] [22] and that the HP1/HP2 difference has at least a modest correlation with this SNP (r 2 = 0.14), we hypothesized that the recurring structural variation that causes the HP1/HP2 difference could be responsible for the association of cholesterol levels with variation in this region.
We were able to obtain genome-wide SNP data from 22,288 individuals of European descent with cholesterol measurements (Online Methods, Supplementary Table 6 and Supplementary Note). In this sample, we found that the GWAS index SNP (rs2000999) was associated as expected with total cholesterol levels (P = 5.15 × 10 −8 ) and LDL cholesterol levels (P = 1.43 × 10 −7 ) (Fig. 5a,b) . We used our approach to impute the most likely HP subtypes in each individual's genome. The imputed HP2 state was associated with cholesterol phenotypes much more strongly (P = 2.8 × 10 −11 for total cholesterol levels and P = 4.3 × 10 −9 for LDL cholesterol levels) than any SNP in the HP region did (Fig. 5a,b) Relationship to LDL cholesterol levels (regression �)
Relationship to total cholesterol levels (regression �) Relationship to LDL cholesterol levels (regression �)
Relationship to total cholesterol levels, conditioned on rs2000999 (regression �)
Relationship to LDL cholesterol levels, conditioned on rs2000999 (regression �) difference, the association at the index SNP was reduced to P = 0.006 for total cholesterol levels and P = 0.004 for LDL cholesterol levels (Fig. 5c,d ) (notably, these are still nominally positive associations, which we further explore below), whereas the HP1/HP2 variant continued to associate more strongly with cholesterol levels (P = 5.95 × 10 −7 for total cholesterol levels and P = 2.02 × 10 −5 for LDL cholesterol levels) in analyses controlling for the GWAS index SNP (Fig. 5e,f) . Both HP2 subtypes (HP2FS and HP2SS) were associated with increased cholesterol levels (Fig. 6a,b) . Although the HP1F and HP1S subtypes segregate on very different SNP haplotype backgrounds (Supplementary Fig. 5 ), they were associated with similar levels of protection from elevated cholesterol levels (Fig. 6a,b) , further supporting the idea that HP structural variation (rather than nearby sequence variation) is the primary driver of the association with these structural alleles.
The GWAS index SNP, rs2000999, is located in a strong enhancer sequence for hepatocytes 38, 39 (the primary source of HP), and the derived allele of this variant associates with reduced HP expression 40, 41 . Although the above analysis more strongly implicated the HP structural variation than this SNP in cholesterol levels, we hypothesized that both the CNV and the rs2000999 variant might affect cholesterol levels through their respective effects on haptoglobin structure and abundance. The derived rs2000999[A] allele is present almost exclusively on HP2 haplotypes (D′ = 0.96), so we examined the effect of each rs2000999 allele on the HP2 background. (The LD between rs2000999 and the HP subtypes is shown in Supplementary Table 7) . We found that, whereas all HP2 alleles were associated with an increase in total and LDL cholesterol levels when compared to HP1 alleles (Fig. 6a,b) , the effect was modestly enhanced for HP2 alleles with the derived rs2000999[A] allele (Fig. 6c,d ). When we corrected for the effect of rs2000999, HP2 alleles on all European SNP haplotype backgrounds (A-C as shown in Fig. 2) were associated with similarly elevated cholesterol levels (Fig. 6e,f) . We believe that the impact of rs2000999 on HP expression explains the residual nominal association that is present at this SNP in analyses conditioning on HP1/HP2. The imputation efficacy of the HP1/HP2 difference is similar for each SNP haplotype background (haplotype A, r 2 = 0.93; haplotype B, r 2 = 0.95; haplotype C, r 2 = 0.95; using SNPs on the Illumina Omni2.5 array), indicating that imperfect imputation is unlikely to have strongly biased the association toward rs2000999 or any other SNP.
This analysis indicates that the association of cholesterol phenotypes with SNPs near HP reflects a complex allelic architecture arising from multiple variants and historical mutations (structural and single nucleotide) at the locus. The status of rs2000999 as the lead (index) SNP at this locus likely reflects a combination of (i) a true genetic effect of this SNP, arising from an effect on HP expression levels and explaining an increase of ~1.49 mg/dl in total cholesterol concentration, and (ii) partial LD (r 2 = 0.14) with a larger effect (2.11 mg/dl increase in total cholesterol concentration) arising from HP structural variation that changes the encoded protein (Supplementary Table 8 ).
DISCUSSION
We have presented multiple lines of evidence that recurrent deletions in HP2 have created new HP1 alleles, a phenomenon that likely explains the low LD between individual SNPs and HP1/HP2. We also found that HP is polymorphic for paralogous gene conversion from HPR, which has obscured the CNV from analysis by earlier sequencing and array-based CNV studies. Although recurring deletions and paralogous gene conversion have historically made studying this structural variation challenging, we demonstrated that HP subtypes can be imputed from SNP haplotypes with high accuracy, an approach that should make it possible to resolve longstanding uncertainty about how genetic variation at HP relates to many human phenotypes. We used this imputation strategy to study HP variation in 22,288 individuals and showed that a complex allelic architecture, shaped most strongly by the HP CNV and also by a cis-acting expression effect, is likely responsible for the strong association of cholesterol levels with 16q22.2 in GWAS 18 .
Haptoglobin interacts with the APOE protein, which is critical to maintaining low total cholesterol and LDL cholesterol levels 42 . Oxidation of APOE impairs its ability to clear plasma lipids 43 . The HP protein directly binds APOE 20, 22 and serves as an APOE antioxidant 20 . The HP2 form of the protein is a less efficient antioxidant than the HP1 form 6 , providing a potential mechanism for the association we observe. Decreased HP levels due to rs2000999[A] may have a similar phenotypic effect but by reducing the level (rather than changing the protein structure) of HP. HP2 and rs2000999[A] could contribute to increased total and LDL cholesterol levels by providing insufficient antioxidant activity for APOE (Fig. 7) .
We found that imputation could be used to extend the analysis of a complex CNV locus to very large samples (n = 22,288) for which SNP data were available. The large sample was critical for resolving multiple effects that are in partial LD and made it possible to appreciate (at high levels of significance) effects that were not apparent in an earlier, smaller study 44 . There are currently controversies about the role of the HP CNV in heart disease, cancer, malaria, Crohn's disease and numerous other human phenotypes. Our approach to imputing complex structural alleles and the imputation resource we make available here (Supplementary Data Set) should make it possible to resolve these questions in a definitive way using large existing SNP Figure 7 A model for the influence of HP genetic polymorphisms on total and LDL cholesterol levels. Because HP serves as an antioxidant for bound APOE 20, 22 and HP1 has greater antioxidant activity than HP2 (ref. 6 ), we propose that HP1 alleles (arising from HP2-to-HP1 deletions) lessen the oxidative burden on APOE, allowing it to more effectively clear plasma lipids. Conversely, the rs2000999[A] allele decreases HP expression 40, 41 and thus reduces antioxidant protection for APOE, contributing to elevated cholesterol levels. npg data sets. A similar approach might be useful at the hundreds of other loci affected by complex and multiallelic CNVs.
GWAS has identified thousands of genetic variants that associate with genetically complex traits. At almost all of these loci, the responsible, functional variants have yet to be found and the underlying allelic architectures are unknown. A particularly intriguing question involves the extent to which the underlying allelic architectures will turn out to be simple (for example, a single responsible functional variant) or complex. Haptoglobin appears to offer an early example of a locus at which an association signal arises from the combined effects of many different common functional alleles with different kinds of effects-a set of many alleles that affect protein structure and an additional allele that affects expression level. It will be interesting and important to understand how widespread such allelic complexity is in human biology.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Sequence data are available on GenBank under accessions KT923758-KT923784.
ONLINE METHODS
Genotyping HP structural variants. To determine the copy number of the HP CNV and the other structural polymorphisms, we used a droplet-based digital PCR method 26 to measure copy number at four locations (boundaries A, B, D and E in Supplementary Fig. 4b ). We designed a pair of PCR primers and a dual-labeled fluorescence-FRET oligonucleotide probe to the sequence of each HP boundary and to a two-copy control locus. Intermediate copy number calls were repeated with triplicate measurements. We used a PCR assay for boundary C to verify the consistency of this boundary in HP2SS haplotypes. Only individuals predicted to carry the HP2SS haplotype on the basis of ddPCR measurements produced an amplicon. A sufficient number of assays were designed such that no single incorrect copy number measurement would mistakenly identify a diploid subtype pair as another subtype pair (Supplementary Table 9 ). Allelic copy numbers were determined on the basis of a biallelic copy number model for each sequence boundary (Supplementary Table 9 ). Hardy-Weinberg equilibrium of HP subtypes (Supplementary Table 10 ) and faithful transmission of HP subtypes in family trios (Supplementary Table 11 ) were verified. One likely three-copy allele was found as well as two rare mutations that interfere with assay amplification (Supplementary Table 12) . Phasing confirmation of recent deletion alleles was performed with Drop-Phase 45 , which is further discussed below (Supplementary Table 13 ). Primer sequences are provided in Supplementary Table 14. SNP haplotype analysis for HP CNV and subtypes. HP structural variants were phased with SNP haplotypes from the 1000 Genomes Project Phase I data and were used to show short haplotypes in four common clusters (Fig. 2) and longer closely related haplotypes in a dendrogram (Fig. 4) . Haplotypes in Figure 2 were clustered with the k-means method using upstream SNP haplotypes only. All recent deletion alleles (HP1S subtype) as shown in Figure 4 were from individuals who have two standard HP2FS SNP haplotypes. Each deletion allele was phased onto the correct SNP haplotype using the DropPhase technique 45 , a new method for phasing based on the idea that physically linked sequences are more frequently partitioned into the same droplets (Supplementary Table 13 ). HP structural variants were also phased with SNPs from common SNP genotyping arrays to evaluate the potential for these variants to be imputed from existing GWAS data. Phasing and encoding for the structural alleles are further discussed in the Supplementary Note. Population sequencing in the CNV region. We performed Sanger sequencing of the CNV region of 27 human haplotypes segregating on diverse SNP haplotype backgrounds and the analogous region of four great apes: chimpanzee, bonobo, gorilla and orangutan. Individual human haplotypes were sequenced by targeting a single structural allele from HP1/HP2 heterozygotes. The primers for the human HP2 allele target the HP2 breakpoint. HP1 haplotypes were obtained with size selection through gel extraction. HP1 sequencing primers were designed to be compatible with the chimpanzee, gorilla and orangutan reference genomes and were also used to sequence the corresponding region in each great ape. All primer pairs are specific to HP and do not amplify haptoglobin-related protein (HPR) or primate haptoglobin (HPP). The hg19 reference genome supplied the human HPR sequence. The chimpanzee and gorilla HP genes were sequenced in samples NS03489 and PR00107, respectively (DNA provided by Coriell Cell Repositories). The sequence for the chimpanzee HPR and HPP genes was supplied by previously sequenced clones (GenBank, M84462.1 and M84463.1) (see Supplementary Figs. 2 and 3 for additional great apes and results by sample and see Supplementary Table 14 for primer sequences).
Creating and testing imputation reference panels. We evaluated the efficacy of imputation for the HP CNV as well as HP subtypes (HP1F, HP1S, HP2FS and HP2SS) using reference panels composed of experimentally determined
